A Randomised Trial of Fluticasone Furoate/Vilanterol (50/25 Μg; 100/25 Μg) on Lung Function in COPD

Respiratory Medicine- United Kingdom

doi 10.1016/j.rmed.2012.12.014

Full Text

Abstract

Available in

Date

April 1, 2013

Authors

Edward M. Kerwin

Catherine Scott-Wilson

Publisher

Elsevier BV

Related search

Corrigendum to “A Randomised Trial of Fluticasone Furoate/Vilanterol (50/25 Μg; 100/25 Μg) on Lung Function in COPD” [Respir Med, 107 (2013) 560–569]

English

Corrigendum to “Fluticasone Furoate/Vilanterol (100/25; 200/25 Μg) Improves Lung Function in COPD: A Randomised Trial” [Respir Med 107 (2013) 550–559]

English

Efficacy and Safety of Fluticasone Furoate 100 Μg Once-Daily in Patients With Persistent Asthma: A 24-Week Placebo and Active-Controlled Randomised Trial

English

Uterotonics in Elective Caesarean Delivery: A Randomised Non-Inferiority Study Comparing Carbetocin 20 Μg and 100 Μg

English

Reduction in All-Cause Mortality With Fluticasone Furoate/Umeclidinium/Vilanterol in COPD Patients

American Journal of Respiratory and Critical Care Medicine

Pulmonary

Critical Care

Respiratory Medicine

Intensive Care Medicine

2020

English

Safety and Efficacy of Recombinant Human Parathyroid Hormone in Adults With Hypoparathyroidism Randomly Assigned to Receive Fixed 25-Μg or 50-Μg Daily Doses

Clinical Therapeutics

Pharmacology

2017

English

PERBANDINGAN EFEKTIVITAS MISOPROSTOL DOSIS 50 Μg DAN 100 Μg TERHADAP KEBERHASILAN KELAHIRAN INDUKSI DI RSU PKU MUHAMMADIYAH YOGYAKARTA

Pharmaciana

2014

Indonesian

INSTEAD: A Randomised Switch Trial of Indacaterolversussalmeterol/Fluticasone in Moderate COPD

European Respiratory Journal

English

A Comparison of the Efficacy and Safety of Once-Daily Fluticasone Furoate/Vilanterol With Twice-Daily Fluticasone Propionate/Salmeterol in Moderate to Very Severe COPD

European Respiratory Journal

English

Amanote Research

A Randomised Trial of Fluticasone Furoate/Vilanterol (50/25 Μg; 100/25 Μg) on Lung Function in COPD

Respiratory Medicine- United Kingdom

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

Corrigendum to “A Randomised Trial of Fluticasone Furoate/Vilanterol (50/25 Μg; 100/25 Μg) on Lung Function in COPD” [Respir Med, 107 (2013) 560–569]

Corrigendum to “Fluticasone Furoate/Vilanterol (100/25; 200/25 Μg) Improves Lung Function in COPD: A Randomised Trial” [Respir Med 107 (2013) 550–559]

Efficacy and Safety of Fluticasone Furoate 100 Μg Once-Daily in Patients With Persistent Asthma: A 24-Week Placebo and Active-Controlled Randomised Trial

Uterotonics in Elective Caesarean Delivery: A Randomised Non-Inferiority Study Comparing Carbetocin 20 Μg and 100 Μg

Reduction in All-Cause Mortality With Fluticasone Furoate/Umeclidinium/Vilanterol in COPD Patients

Safety and Efficacy of Recombinant Human Parathyroid Hormone in Adults With Hypoparathyroidism Randomly Assigned to Receive Fixed 25-Μg or 50-Μg Daily Doses

PERBANDINGAN EFEKTIVITAS MISOPROSTOL DOSIS 50 Μg DAN 100 Μg TERHADAP KEBERHASILAN KELAHIRAN INDUKSI DI RSU PKU MUHAMMADIYAH YOGYAKARTA

INSTEAD: A Randomised Switch Trial of Indacaterolversussalmeterol/Fluticasone in Moderate COPD

A Comparison of the Efficacy and Safety of Once-Daily Fluticasone Furoate/Vilanterol With Twice-Daily Fluticasone Propionate/Salmeterol in Moderate to Very Severe COPD